highmobilitygroupbox
chromosom
protein
protein
amino
acid
ubiquit
abund
nuclear
protein
eukaryot
cell
nuclear
protein
stabil
nucleosom
facilit
dna
replic
recombin
repair
gene
transcript
nuclear
serv
import
role
maintain
nuclear
stabil
stress
howev
increas
number
previou
studi
reveal
extracellular
exert
action
distinctli
differ
compar
intracellular
function
abl
rapidli
mobil
extracellular
space
releas
passiv
cytokin
cell
undergo
unprogram
cell
death
necrosi
releas
extracellularli
extrem
potent
innat
signal
initi
host
defens
mechan
tissu
regener
identifi
macrophagestimul
factor
proinflammatori
mediat
serum
level
report
rais
patient
acut
organ
injuri
includ
trauma
stroke
acut
myocardi
infarct
acut
respiratori
distress
acut
pancreat
ischemiareperfus
injuri
addit
increas
observ
circul
level
protein
posit
correl
sever
diseas
human
anim
model
complet
inhibit
neutral
may
attenu
sever
diseas
decreas
incid
organ
dysfunct
improv
surviv
consequ
burgeon
interest
therapeut
target
among
strategi
investig
agent
bind
neutral
activ
includ
antibodi
rais
molecul
inhibit
activ
interact
specif
receptor
gather
attent
two
separ
characterist
dnabind
domain
term
hmg
b
box
domain
contain
amino
acid
residu
molecular
mass
kda
b
box
domain
contain
proinflammatori
cytokin
function
molecul
wherea
box
region
exert
antagonist
antiinflammatori
effect
put
therapeut
target
purifi
box
identifi
antagonist
proinflammatori
action
b
box
sinc
compet
receptor
activ
attenu
releas
proinflammatori
cytokin
box
markedli
amelior
damag
statu
exampl
administr
box
mous
model
transient
coronari
vessel
occlus
associ
mark
attenu
tissu
damag
wherea
system
administ
recombin
protein
increas
sever
damag
appreci
extent
administr
box
markedli
enhanc
cardiac
allograft
surviv
associ
reduc
level
express
tumor
necrosi
factor
tnf
interferon
ifn
allograft
administr
box
protein
wildtyp
mice
inject
directli
hippocampu
led
mark
attenu
seizur
sever
model
emul
collageninduc
arthriti
inflamm
damag
markedli
attenu
inhibitor
includ
antibodi
box
protein
addit
administr
box
afford
high
level
protect
sepsi
lethal
reduc
mean
arthriti
score
circumv
diseaseinduc
weight
loss
histolog
sever
arthriti
consequ
counteract
extracellular
specif
antagonist
box
may
offer
novel
method
therapeut
intervent
rapid
effici
costeffect
protein
express
purif
strategi
requir
product
therapeut
protein
small
ubiquitinlik
modifi
sumo
fusion
express
system
abl
meet
requir
sumo
famili
protein
function
posttransl
modifi
make
coval
revers
connect
protein
sumo
associ
enzym
present
eukaryot
highli
conserv
yeast
human
although
absent
prokaryot
sumo
fuse
nterminu
heterolog
protein
reveal
improv
fold
protein
interest
enhanc
level
express
protect
protein
degrad
via
chaperon
properti
sumofus
protein
may
cleav
sumo
proteas
recogn
threedimension
structur
sumo
protein
rather
specif
peptid
sequenc
target
protein
obtain
nativ
nterminu
intact
aim
present
studi
develop
sumofus
express
system
order
express
purifi
high
level
box
protein
primer
synthes
shanghai
generay
biotech
co
ltd
shanghai
china
restrict
enzym
stui
hindiii
purchas
new
england
biolab
ltd
beij
china
taq
dna
polymeras
obtain
takara
biotechnolog
dalian
co
ltd
dalian
china
revers
transcriptionpolymeras
chain
reaction
rtpcr
purif
gel
extract
plasmid
miniprep
kit
purchas
axygen
corn
inc
corn
ny
usa
express
vector
psumomut
modifi
obtain
novobio
scientif
shanghai
china
escherichia
coli
compet
cell
cell
respect
also
obtain
novobio
scientif
affin
column
merck
kgaa
darmstadt
germani
sumo
proteas
purchas
novobio
scientif
cell
count
kit
purchas
dojindo
molecular
technolog
inc
rockvil
md
usa
lipopolysaccharid
lp
sigmaaldrich
st
loui
mo
usa
enzymelink
immunosorb
assay
elisa
kit
obtain
r
system
china
co
ltd
shanghai
china
fulllength
cdna
certain
synonym
mutat
incorpor
render
appropri
prokaryot
express
use
templat
primer
synthes
accord
sequenc
modifi
cdna
sequenc
primer
follow
forward
revers
thermal
cycl
condit
follow
min
follow
cycl
sec
sec
sec
use
thermal
cycler
biorad
laboratori
inc
hercul
ca
usa
briefli
pcr
reaction
mixtur
contain
buffer
dntp
taq
dna
polymeras
mm
sens
antisens
primer
cdna
pcr
product
digest
restrict
enzym
stui
hindiii
ligat
predigest
vector
psumomut
make
fusion
protein
express
vector
accuraci
insert
dna
segment
confirm
dna
sequenc
genewix
suxhou
china
aliquot
recombin
plasmid
harbor
accur
sequenc
fusion
gene
transfer
cell
agil
technolog
inc
santa
clara
ca
usa
singl
transform
coloni
inocul
ml
lysogeni
broth
lb
contain
kanamycin
sangon
biotech
co
ltd
shanghai
china
agit
shaker
zhicu
shanghai
china
g
overnight
total
cultur
transfer
ml
lb
medium
follow
day
cultur
agit
g
absorb
nm
reach
isopro
iptg
sangon
biotech
co
ltd
ad
cultur
final
concentr
mm
follow
induct
agit
g
h
sampl
prepar
subsequ
express
analysi
sdspage
biorad
laboratori
inc
use
sdspage
gel
amresco
llc
solon
oh
usa
cell
collect
centrifug
g
min
room
temperatur
follow
iptg
induct
cell
pellet
l
bacterium
solut
resuspend
ml
bind
buffer
lyse
sonic
use
ultrason
cell
disrupt
system
thermo
fisher
scientif
waltham
usa
paramet
sonic
adjust
amplitud
min
sonic
sec
sonic
sec
puls
lysat
subsequ
centrifug
g
min
supernat
appli
onto
affin
column
preequilibr
bind
buffer
follow
wash
column
wash
buffer
mm
trishcl
ph
mm
imidazol
nacl
bound
protein
elut
elut
buffer
mm
trishcl
ph
mm
imidazol
nacl
fraction
collect
prior
sdspage
analysi
purifi
fusion
protein
dialyz
overnight
mm
trishcl
ph
buffer
total
unit
sumo
fusion
protein
ad
mixtur
incub
min
cleav
sampl
appli
onto
affin
column
separ
target
protein
histag
sumo
sumo
proteas
purifi
protein
dialyz
overnight
phosphatebuff
salin
pb
ph
concentr
purifi
evalu
use
nanodrop
uvvi
spectrophotomet
thermo
fisher
scientif
wilmington
de
usa
murin
macrophagelik
raw
cell
purchas
cell
bank
shanghai
institut
biolog
scienc
chines
academi
scienc
shanghai
china
macrophagelik
raw
cell
cultur
dulbecco
modifi
eagl
medium
supplement
fetal
bovin
serum
uml
penicillin
uml
streptomycin
invitrogen
life
technolog
carlsbad
ca
usa
supernat
replac
fresh
medium
everi
h
cell
healthi
condit
viabil
use
subsequ
experi
total
macrophagelik
raw
cell
suspens
seed
plate
densiti
lp
ad
final
concentr
follow
h
incub
lp
protein
final
concentr
ad
experiment
group
exp
ident
volum
pb
ad
control
group
ctrl
blank
control
blank
establish
pb
lack
lp
stimul
follow
h
incub
medium
ad
correspond
well
plate
incub
addit
h
absorb
wavelength
nm
determin
use
elisa
reader
biorad
biorad
laboratori
inc
cell
viabil
calcul
accord
follow
equat
cell
viabil
aexp
ablank
actrl
ablank
data
acquir
experi
perform
triplic
concentr
cell
cultur
supernat
determin
elisa
accord
manufactur
instruct
result
express
mean
standard
deviat
statist
analys
perform
use
pair
student
ttest
pair
comparison
made
relev
use
graphpad
prism
graphpad
softwar
inc
la
jolla
ca
usa
p
consid
indic
statist
signific
differ
pcr
product
digest
restrict
enzym
stui
hindiii
ligat
predigest
psumomut
vector
creat
fusion
protein
express
vector
fig
two
restrict
enzym
site
xbal
xhol
locat
end
sequenc
fusion
protein
restrict
enzym
analysi
plasmid
xbal
xhol
perform
confirm
construct
obtain
fig
recombin
plasmid
harbor
accur
sequenc
fusion
gene
transfer
cell
total
two
singl
transform
coloni
inocul
cultur
larg
scale
prior
iptg
induct
coloni
express
high
level
fusion
protein
follow
mm
iptg
induct
h
fig
lane
follow
iptg
induct
cell
collect
centrifug
cell
pellet
resuspend
bind
buffer
lyse
sonic
result
sdspage
experi
reveal
fusion
protein
express
precipit
supernat
induc
mm
iptg
h
fig
lane
supernat
load
onto
affin
column
preequilibr
bind
buffer
protein
histag
retain
column
wherea
protein
lack
histag
remov
wash
buffer
bound
fusion
protein
elut
elut
buffer
contain
mm
imidazol
puriti
reveal
fig
lane
fusion
protein
releas
cleav
purifi
sumo
proteas
result
sdspage
experi
reveal
almost
fusion
protein
cleav
within
min
fig
lane
digest
mixtur
subsequ
reload
onto
affin
column
purif
sinc
noncleav
fusion
protein
sumo
fragment
sumo
proteas
possess
histag
retain
column
releas
target
protein
obtain
flowthrough
puriti
reveal
fig
lane
purifi
protein
dialyz
overnight
pb
ph
final
concentr
purifi
protein
total
yield
target
protein
determin
mgml
mg
respect
previou
result
indic
protein
may
releas
lpsactiv
raw
cell
may
contribut
lpsregul
cell
viabil
assess
antiinflammatori
function
box
follow
express
purif
cell
viabil
evalu
follow
lp
treatment
without
incub
treatment
lp
h
protein
final
concentr
ad
experiment
group
incub
h
control
group
lp
stimul
demonstr
impair
cell
viabil
throughout
durat
experi
contrast
cell
viabil
gradual
increas
time
addit
protein
increas
dosedepend
fig
cell
viabil
h
control
group
group
treat
protein
p
group
treat
protein
p
releas
earli
stage
onset
system
inflammatori
respons
furthermor
protein
releas
lpsactiv
raw
cell
demonstr
stimul
macrophag
releas
therefor
object
present
studi
observ
effect
purifi
protein
level
stimul
supernat
level
control
group
reach
maximum
h
tabl
wherea
level
peak
h
tabl
ii
level
reduc
immedi
follow
h
incub
compar
control
group
p
inhibitori
effect
timedepend
maximum
inhibit
achiev
follow
h
incub
reach
p
tabl
level
observ
upon
incub
inhibit
reach
maximum
h
postpon
compar
control
group
tabl
ii
theoret
size
sumofus
protein
kda
howev
size
sumofus
protein
determin
sdspage
analysi
appear
margin
larger
predict
size
possibl
explan
phenomenon
may
attribut
sumo
protein
sumo
ubiquitinlik
protein
abl
form
tertiari
structur
consequ
lead
increas
molecular
weight
commonli
observ
sumofus
protein
express
soughtaft
target
protein
lowmolecularweight
protein
kda
sumo
proteas
observ
success
cleav
broad
rang
size
kda
partner
protein
fuse
sumo
achiev
obtain
purifi
protein
sumofus
express
system
use
present
studi
also
support
capabl
express
system
accommod
sumo
fusion
partner
protein
sinc
box
region
exert
antagonist
antiinflammatori
effect
therapeut
potenti
ultim
goal
express
purifi
therapeut
intervent
product
therapeut
protein
requir
rapid
effici
costeffect
furthermor
tag
remov
order
protein
activ
neither
attenu
modifi
differ
method
use
preliminari
investig
express
protein
fail
yield
satisfactori
result
data
shown
yield
fusion
protein
obtain
glutathion
stransferas
gst
tag
accept
although
remov
gst
tag
affect
activ
target
protein
express
target
protein
without
gst
tag
led
low
solubl
one
advantag
sumofus
technolog
use
present
studi
mg
solubl
protein
puriti
obtain
l
bacterium
solut
sumo
fusion
report
enhanc
protein
express
solubl
purif
prokaryot
fusion
technolog
abl
improv
express
recombin
protein
protect
degrad
addit
sumo
extern
hydrophil
surfac
inner
hydrophob
core
may
exert
detergentlik
effect
otherwiseinsolubl
protein
furthermor
presenc
histag
sumo
sumo
proteas
provid
simplifi
mean
purif
obtain
high
level
target
protein
notabl
lack
endogen
sumo
proteas
prokaryot
facilit
use
sumo
purif
tag
e
coli
sumo
proteas
accur
effici
agent
cleav
sumo
tag
allow
retent
desir
nterminu
without
extran
residu
usual
produc
proteas
sinc
sumo
proteas
recogn
tertiari
structur
sumo
tag
instead
peptid
sequenc
use
sumofus
express
system
present
studi
overcom
sever
problem
includ
low
protein
yield
precipit
target
protein
failur
recov
activ
structur
intact
protein
recombin
box
antagonist
b
box
fulllength
protein
consid
compet
receptor
activ
previou
studi
report
recombin
protein
may
attenu
develop
inflammatori
diseas
thromboangi
obliteran
rat
model
provid
evid
may
put
therapeut
protein
treatment
certain
inflammatori
diseas
furthermor
truncat
individu
structur
domain
reveal
dnabind
motif
specif
antagon
activ
rescu
mice
lethal
sepsi
accordingli
strategi
target
specif
antibodi
antagonist
potenti
use
therapi
lethal
system
inflammatori
diseas
recombin
box
obtain
sumo
fusion
technolog
present
studi
demonstr
attenu
level
supernat
amelior
lpsimpair
cell
viabil
addit
technolog
allow
product
activ
protein
high
yield
puriti
valuabl
produc
high
level
target
protein
subsequ
therapeut
studi
